The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs
Abstract
We prospectively compared the impact on quality of life and cost effectiveness between ablation and medication as an initial strategy for patients with paroxysmal supraventricular tachycardia (SVT). Seventy-nine consecutive patients with newly documented paroxysmal SVT were treated with either ablation or medication. Health surveys (SF-36 and disease-specific questions) were obtained at baseline and after 12 months of follow up. Cost of health care utilization for the 6 months before and after treatment were measured. Both medication and ablation improved quality of life. However, ablation improved quality of life in more general health categories than medication. At follow up, ablation was associated with significantly improved quality of life in the bodily pain (63+/-24 vs 81+/-20, p <0.005), general health (69+/-21 vs 79+/-21, p <0.05), vitality (55+/-21 vs 66+/-22, p <0.05), and role emotion (78+/-36 vs 94+/-17, p <0.05) categories when compared with medication. Although both medication and ablation decreased frequency of disease-specific symptoms, ablation resulted in complete amelioration of symptoms in more patients (33% vs 74%). Potential long-term costs were similar for medication and ablation. In conclusion, ablation improves health-related quality of life to a greater extent, and in more aspects of general and disease-specific health than medication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With regard to the costs of radiofrequency catheter ablation procedures, variable data have been reported in literature (from $5000 to $16 000), varying not only according to setting and country but also according to consideration of actual costs or billed hospital charges.258”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [258]
In the citing paper
“In patients with symptoms that can be controlled with medications, the upfront cost of ablation therapy is equalled, with time, by the cumulative cost of medical therapy, usually after a period of around 10 years.258”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [258]
In the citing paper
“Every study has demonstrated an improvement in self-reported QoL following ablation.2,245,246,254 -256,258,424,425”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [258]
In the citing paper
“Almost all of the studies examining QoL, measured with validated questionnaires, have been conducted in patients undergoing catheter ablation for SVT, 245,246,254 - 256,258,424,425 although often without a comparison group.”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [258]
In the citing paper
“Several studies have investigated patient-reported QoL, 2,245,246,254 -256,258,424,425 and these may offer some insight into patient preferences for treatment where particular therapies result in improvements in QoL.”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [258]
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339
Jackman, W. M., Wang, X., Friday, K. J., Roman, C. A., Moulton, K. P., Beckman, K. J., McClelland, J. H., Twidale, N., Hazlitt, H. A., Prior, M. I., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106063242301 · Cited by 1,422
Jackman, W. M., Beckman, K. J., McClelland, J. H., Wang, X., Friday, K. J., Roman, C. A., MOULTON, K. P., Twidale, N., Hazlitt, H. A., PRIOR, M. I., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270504 · Cited by 1,156
Bubien, R. S., Knotts-Dolson, S. M., Plumb, V. J., & Kay, G. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1585 · Cited by 284
Kalbfleisch, S. J., Calkins, H. G., Langberg, J. J., El-Atassi, R., León, A. R., Borganelli, M., & Morady, F. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90621-s · Cited by 66
Hogenhuis, W., Stevens, S. K., Wang, P. J., Wong, J. B., Manolis, A. S., Estes, N. A. M., & Pauker, S. G. (1993) · PubMed · Cited by 62
LAU, C., Tai, Y., & Lee, P. W. H. (1995) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1995.tb02541.x · Cited by 57
de Buitleir, M., de Sousa, J., Boiling, S. F., El-Atassi, R., Calkins, H., Langberg, J. J., Kou, W. H., & Morady, F. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90325-f · Cited by 47
Supraventricular tachyarrhythmias: Pharrnacologic versus nonpharrnacologic approaches
Chun, H. M., & Sung, R. J. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30023-2 · Cited by 10
Cited by
Sorted by citations
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,312
Blomstrom-Lundqvist (2003) · doi:10.1161/01.cir.0000091380.04100.84 · Cited by 955
Blomström‐Lundqvist, C., Scheinman, M. M., Aliot, E., Alpert, J. S., Calkins, H. G., Camm, A. J., Campbell, W. B., Haines, D. E., Kück, K., Lerman, B. B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.013 · Cited by 684
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
Blomström‐Lundqvist, C., Scheinman, M. M., Aliot, E., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kück, K., Lerman, B. B., et al. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.002 · Cited by 267
Metadata
- Authors
- Bathina, M., Mickelsen, S., Brooks, C., Jaramillo, J., Hepton, T., & Kusumoto, F.
- Affiliations
- Lovelace Medical Center (US)
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1998-09
- Volume
- 82
- Issue
- 5
- Pages
- 589-593
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2053154502
- Cited by
- 109
- References
- 12
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2022: 2 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 9 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- paroxysmal supraventricular tachycardia, radiofrequency catheter ablation, antiarrhythmic drugs, quality of life, cost-effectiveness, health care costs, SF-36, symptom burden, initial treatment strategy
- MeSH terms
- Activities of Daily Living, Adult, Aged, Anti-Arrhythmia Agents, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, New Mexico, Quality of Life, Tachycardia, Paroxysmal, Tachycardia, Supraventricular, Treatment Outcome, Health Care Costs, Patient Satisfaction, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
